A BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB VERSUS BEVACIZUMAB PLUS VORINOSTAT IN ADULTS WITH RECURRENT GLIOBLASTOMA FINAL RESULTS

被引：0

作者：

Puduvalli, Vinay ^{[1
]}

Wu, Jing ^{[2
]}

Yuan, Ying ^{[3
]}

Armstrong, Terri ^{[2
]}

Wu, Jimin ^{[3
]}

Giglio, Pierre ^{[4
]}

Xu, Jihong ^{[1
]}

Colman, Howard ^{[5
,6
]}

Walbert, Tobias ^{[7
]}

Raizer, Jeffrey ^{[8
]}

Groves, Morris ^{[9
]}

Iwamoto, Fabio ^{[10
]}

Tran, David ^{[11
]}

Avgeropoulos, Nicholas ^{[12
]}

Paleologos, Nina ^{[13
]}

Fink, Karen ^{[14
]}

Peereboom, David ^{[15
]}

Chamberlain, Marc ^{[16
]}

Merrell, Ryan ^{[17
]}

Penas-Prado, Marta ^{[3
]}

Yung, W. K. Alfred ^{[18
]}

Gilbert, Mark ^{[2
]}

机构：

[1] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA

[2] NCI, Neurooncol Branch, CCR, NIH, Bethesda, MD 20892 USA

[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[4] Ohio State Univ, Columbus, OH 43210 USA

[5] Univ Utah, Dept Neurosurg, Huntsman Canc Inst, Salt Lake City, UT USA

[6] Univ Utah, Clin Neurosci Ctr, Salt Lake City, UT USA

[7] Henry Ford Hosp, Detroit, MI 48202 USA

[8] Northwestern Univ, Chicago, IL 60611 USA

[9] Texas Oncol Austin Brain Tumor Ctr, Austin, TX USA

[10] Columbia Univ, New York, NY USA

[11] Univ Florida, Gainesville, FL USA

[12] Univ Florida, Orlando, FL USA

[13] Advocate Hlth Care, Chicago, IL USA

[14] Baylor Univ, Dallas, TX USA

[15] Cleveland Clin, Cleveland, OH 44106 USA

[16] Univ Washington, Seattle, WA 98195 USA

[17] Northshore Univ, Evanston, IL USA

[18] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA

来源：

NEURO-ONCOLOGY | 2018年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ACTR-13

引用

页码：13 / 13

页数：1

共 50 条

[1] A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma
Puduvalli, Vinay K.
Wu, Jing
Yuan, Ying
Armstrong, Terri S.
Vera, Elizabeth
Wu, Jimin
Xu, Jihong
Giglio, Pierre
Colman, Howard
Walbert, Tobias
Raizer, Jeffrey
Groves, Morris D.
Tran, David
Iwamoto, Fabio
Avgeropoulos, Nicholas
Paleologos, Nina
Fink, Karen
Peereboom, David
Chamberlain, Marc
Merrell, Ryan
Prado, Marta Penas
Yung, W. K. Alfred
Gilbert, Mark R.
NEURO-ONCOLOGY, 2020, 22 (10) : 1505 - 1515
[2] Brain Tumor Trials Collaborative Bayesian Adaptive Randomized Phase II trial of bevacizumab plus vorinostat versus bevacizumab alone in adults with recurrent glioblastoma (BTTC-1102)
Puduvalli, Vinay K.
Wu, Jing
Yuan, Ying
Armstrong, Terri S.
Groves, Morris D.
Raizer, Jeffrey J.
Giglio, Pierre
Colman, Howard
Peereboom, David M.
Walbert, Tobias
Avgeropoulos, Nicholas George
Iwamoto, Fabio Massaiti
Chamberlain, Marc C.
Paleologos, Nina
Fink, Karen L.
Merrell, Ryan
Yung, W. K. Alfred
Gilbert, Mark R.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[3] Bevacizumab versus bevacizumab plus vorinostat in adults with recurrent malignant glioma: Results of a phase I part of a phase I/II trial
Wu, Jing
Groves, Morris D.
Gilbert, Mark R.
Hess, Kenneth R.
Loch, Carolyn Sue
Ictech, Sandra
De Groot, John Frederick
Conrad, Charles A.
Yung, W. K. Alfred
Puduvalli, Vinay K.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[4] A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma
Shiao-Pei Weathers
Xiaosi Han
Diane D. Liu
Charles A. Conrad
Mark R. Gilbert
Monica E. Loghin
Barbara J. O’Brien
Marta Penas-Prado
Vinay K. Puduvalli
Ivo Tremont-Lukats
Rivka R. Colen
W. K. Alfred Yung
John F. de Groot
Journal of Neuro-Oncology, 2016, 129 : 487 - 494
[5] A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma
Weathers, Shiao-Pei
Han, Xiaosi
Liu, Diane D.
Conrad, Charles A.
Gilbert, Mark R.
Loghin, Monica E.
O'Brien, Barbara J.
Penas-Prado, Marta
Puduvalli, Vinay K.
Tremont-Lukats, Ivo
Colen, Rivka R.
Yung, W. K. Alfred
de Groot, John F.
JOURNAL OF NEURO-ONCOLOGY, 2016, 129 (03) : 487 - 494
[6] A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma
Weathers, Shiao-Pei S.
Han, Stan Xiaosi
Liu, Diane D.
Conrad, Charles A.
Gilbert, Mark R.
Loghin, Monica Elena
O'Brien, Barbara Jane
Penas-Prado, Marta
Puduvalli, Vinay K.
Tremont-Lukats, Ivo
Yung, W. K. Alfred
De Groot, John Frederick
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[7] FINAL ANALYSIS OF THE BELOB TRIAL (A RANDOMIZED PHASE II STUDY ON BEVACIZUMAB VERSUS BEVACIZUMAB PLUS LOMUSTINE VERSUS LOMUSTINE SINGLE AGENT IN RECURRENT GLIOBLASTOMA) AND FIRST RADIOLOGY REVIEW RESULTS
Taal, W.
Oosterkamp, H. M.
Walenkamp, A. M. E.
Dubbink, H. J.
Beerepoot, L. V.
Hanse, M.
Buter, J.
Honkoop, A.
Boerman, D.
Vos, F. Y. F.
Dinjens, W. N. M.
Enting, R. H.
Taphoorn, M. J. B.
van den Berkmortel, F. W. P. J.
Jansen, R.
Brandsma, D.
Bromberg, J. E.
van Heuvel, I.
Vernhout, R. M.
van der Holt, B.
van den Bent, M. J.
NEURO-ONCOLOGY, 2014, 16
[8] FINAL ANALYSIS OF THE BELOB TRIAL (A RANDOMIZED PHASE II STUDY ON BEVACIZUMAB VERSUS BEVACIZUMAB PLUS LOMUSTINE VERSUS LOMUSTINE SINGLE AGENT IN RECURRENT GLIOBLASTOMA) AND FIRST RADIOLOGY REVIEW RESULTS
Taal, Walter
Enting, Roelien
Taphoorn, Martin
Smits, Marion
Dubbink, Hendrikus
Beerepoot, Laurens
Hanse, Monique
Bralten, Linda
Oosterkamp, Hendrika
Walenkamp, Annemiek
Buter, Jan
Honkoop, Aafke
Boerman, Dolf
de Vos, Filip
Bromberg, Jacoline
Vernhout, Rene
van der Holt, Bronno
van den Bent, Martin
NEURO-ONCOLOGY, 2014, 16
[9] Vorinostat, temozolomide, and bevacizumab for patients with recurrent glioblastoma: A phase I/II trial
Peters, Katherine B.
Vredenburgh, James J.
Desjardins, Annick
Friedman, Henry S.
Herndon, James Emmett
Coan, April D.
McSherry, Frances
Lipp, Eric S.
Brickhouse, Alise
Massey, Woody C.
Reardon, David A.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[10] Phase II study of bevacizumab and vorinostat for recurrent glioblastoma.
Ghiaseddin, Ashley
Reardon, David A.
Massey, Woody
Mannerino, Alexandra
Lipp, Eric S.
Herndon, James E.
McSherry, Frances
Desjardins, Annick
Randazzo, Dina M.
Vlahovic, Gordana
Friedman, Henry S.
Peters, Katherine B.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

← 1 2 3 4 5 →